Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models
Pengfei Xu(Southern Medical University), Chengfei Liu(UC Davis Comprehensive Cancer Center)
Cited by 20
Related Papers
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment
|Journal for ImmunoTherapy of Cancer|2023|64
NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2
|Journal of Experimental & Clinical Cancer Research|2019|59
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer
|Oncogene|2023|18